IL6 and breast cancer: Adipocytes-derived leptin and IL-6 have known to activate Jak/STATs and PI3K/AKT pathways and to increase the expression of Lysyl Hydroxylase-2 in breast cancer cells leading to tumor progression including epithelial-mesenchymal transition and metastasis 11, 12.